Story Poster
Georgia Football

Georgia-Florida matchup watch: Kyle Pitts vs. UGA secondary

November 6, 2020

Do you remember when the Georgia secondary got torched by Alabama a few weeks ago?

With Florida’s offense, that can happen again. No, Florida is not as good as Alabama, and their offense is not as lethal either, but Florida has some elite weapons.

Most notable is tight end Kyle Pitts. He is 6’6” and 246 lbs. He is fast, he is a smooth runner and he has good hands.

He has 355 yards and seven touchdowns in four games this season. That sums up how good he is. 

Pitts is a glorified wide receiver that can line up anywhere on the field. 

“With all of my history in the SEC, I don’t know that there has been a guy like that,” Kirby Smart said.

Georgia is going to have to defend Kyle Pitts without Richard LeCounte in the secondary after LeCounte was injured in a traffic accident on Halloween night. That is a huge blow to the Georgia defense. 

Georgia has not struggled against tight ends this year, but last season that was an issue against Notre Dame- and this is virtually the same Georgia defense, give or take a couple of players. Cole Kmet had 108 yards receiving and a touchdown on nine catches in Athens last year. 

Kmet went on to the NFL, but Pitts is the more explosive player. 

With LeCounte out, Lewis Cine and Christopher Smith will have to pick up his slack in the secondary. There are going to be a lot of times where those safeties are going to have to pick up Pitts in coverage. Monty Rice is likely to be involved in coverage as well. 

The bottom line is that Pitts is a weapon and he can line up anywhere. Don’t be surprised if he gets covered by all sorts of players. 

Pitts is averaging almost two touchdowns per game. He has good rapport with Kyle trask. 

The Georgia secondary is key in this game. The defense can’t get torched like they did against Alabama, and stopping Pitts is a huge part of that.  


subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.